Caitong International Asset Management’s Rapid Micro Biosystems RPID Stock Holding History

Caitong International Asset Management’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61	Buy	+35	New	+$74	﹤0.01%	2310

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EFA

Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Caitong International Asset Management's RPID Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Rapid Micro Biosystems (RPID) in Q2 2026: 35 shares worth $61. The stake represents ﹤0.01% of the portfolio and ranks #2310 among its holdings.

34 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

Caitong International Asset Management held 35 shares of Rapid Micro Biosystems worth $61 as of Q2 2026.
Rapid Micro Biosystems was a new Caitong International Asset Management position in Q2 2026.
Rapid Micro Biosystems made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2310 holding.
34 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.